|Articles|March 1, 2009
Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution
Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















